ClinicalTrials.gov
public full text
Public Domain
Effect of Intranasal Anti-IgE Antibodies on IgE Production
In this study, participants will receive either intranasal anti-IgE-antibodies (n=5) or intranasal allergen (n=5) or intranasal placebo (n=5). Blood samples will be obtained before nasal administration of study drugs and 3, 5 and 8 weeks thereafter. In the serum samples, specific and total IgE levels will be assessed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy#897207
- ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults#869829
- Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management#481481
- Study of Mepolizumab Safety Syringe in Asthmatics#847260
- Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma#995390
Record · ID 825752
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive